Dr. Evan Michael Graboyes, MD

Dr. Graboyes practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. Graboyes' NPI, 1760778682, was assigned on June 20, 2011. Dr. Graboyes graduated from Washington University School of Medicine in 2011. Dr. Graboyes holds South Carolina license 39154.

Dr. Graboyes' primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. Graboyes' primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. Graboyes is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Graboyes to 3 more group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Graboyes practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Graboyes' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Graboyes' licenses on file in 2 states: South Carolina and Missouri.

CMS data shows 63 Medicare services from Dr. Graboyes across 3 procedure codes in 2024, for 35 Medicare patients. Medicare paid $3,512 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 35 Medicare patients who saw Dr. Graboyes in 2024. The largest group is 65 to 74, with 17 patients. 74% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Graboyes' median patient age at 68, with 36% women.

In 2024, Dr. Graboyes wrote 30 Medicare Part D claims. 90% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $869 in total drug cost. In 2022, CMS named 42 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Graboyes for performance year 2024, reported as part of a group. Dr. Graboyes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of melanoma (skin cancer) excision by Dr. Graboyes, more than 67% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 135 papers to Dr. Graboyes, published from 2011 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Plastic Surgery Procedures. Dr. Graboyes has published most often in JAMA Otolaryngol Head Neck Surg. Dr. Graboyes' most frequent co-authors are Brian Nussenbaum, MD, Joseph Zenga, MD and Patrik Pipkorn, MD.

Dmand AI links Dr. Graboyes to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell and Head and Neck Neoplasms. Medical University of South Carolina sponsors the most, 4.

CMS Open Payments shows 37 general payments to Dr. Graboyes from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. Merck Sharp & Dohme Corporation paid the most, $15,818.

Dr. Graboyes graduated from Washington University School of Medicine in 2011.